For treatment of: Nitroglycerin, Relief and short-term prevention of angina attacks.Nitroglycerin
- For the treatment of internal organs: heart.
- Appointment: stenocardia.
- Indications for use:
Relief and short-term prevention of angina attacks.
Hypersensitivity to nitrates, shock, collapse, simultaneous administration of PDE-5 inhibitors (sildenafil, tadalafil, vardenafil, etc.), age up to 18 years ( efficacy and safety have not been established for the age under 18 years).
Craniocerebral hypertension, cardiac tamponade, uncontrolled hypovolemia, in patients with heart failure with normal or low pulmonary artery pressure, arterial hypotension (systolic blood pressure less than 90 mm Hg. St.), angle-closure glaucoma with high intraocular pressure, severe anemia, hyperthyroidism, toxic pulmonary edema, subarochnoid hemorrhage, recent head trauma, hemorrhagic stroke, conditions accompanied by a decrease in left ventricular filling pressure (acute myocardial infarction, isolated mitral stenosis, constrictive pericarditis), idiopathic hypertrophic subaortic stenosis, cerebral circulation disorders, severe renal and/or hepatic insufficiency (risk of developing methemoglobinemia).
Nitroglycerin with dextrose containing the active substance: nitroglycerin (in terms of 100% substance) -0.5 mg, auxiliary substance: dextrose - 4.5 mg. Excipients: aspartame - 0.3 mg, colloidal silicon dioxide (Aerosil) -0.9 mg, stearic acid - 0.4 mg, croscarmellose sodium -1.0 mg, potato starch -2.6 mg, microcrystalline cellulose -34.8 mg.